Xilio Therapeutics, Inc. (XLO)
9.00
+0.09
(+1.01%)
USD |
NASDAQ |
Sep 09, 14:00
Xilio Therapeutics Profit Margin (Quarterly) : -34.09% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -34.09% |
| March 31, 2026 | -75.34% |
| December 31, 2025 | 75.70% |
| September 30, 2025 | -85.42% |
| June 30, 2025 | -196.0% |
| Date | Value |
|---|---|
| March 31, 2025 | -452.7% |
| December 31, 2024 | -759.5% |
| September 30, 2024 | -619.5% |
| June 30, 2024 | -590.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cue Biopharma, Inc. | -1.94K% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -60.96% |
| Return on Assets | -14.71% |
| Return on Invested Capital | -51.05% |
| Gross Profit Margin (Quarterly) | 98.23% |
| Operating Margin (Quarterly) | -18.68% |
| Return on Net Operating Assets | -163.2% |